Meet these key lung cancer researchers
Meet five leading lung cancer researchers whose dedication is changing the face of the disease. Here, you’ll discover their groundbreaking work and hear from them in personal video interviews. Their research is a beacon of hope and a testament to the power of science in our shared fight against lung cancer. If you are looking for an expert opinion, this is the place to start. Join us in honoring their contributions that drive us closer to a cure.
Dr. Alice Shaw
Her patients call her a super hero and a rock star, but, in real life, Dr. Alice Shaw is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School.
In addition to caring for patients with lung cancer, Dr. Shaw also performs clinical and translational research.
Dr. Charles Rudin
Dr. Rudin serves as the Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and, as such, he wears many hats. His clinic treats patients with all types of lung cancer, but Dr. Rudin is an expert opinion leader in Small Cell Lung Cancer, an aggressive (fast-growing) cancer that forms in tissues of the lung and can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope and is often metastatic (spread to other parts of the body) at the time of diagnosis.
Dr. Jessica Donington
Dr. Donington is a Professor in Surgery and chief of the section of Thoracic Surgery at the University of Chicago Medical Center. Her research centers around finding lung cancer early. Low dose CT scans are key in early detection. Dr. Donington is also a past recipient of a LCFA lung cancer research grant and now serves on LCFA’s Scientific Advisory Board.
Dr. David Johnson
Dr. David Johnson is the R. Ellwood Jones, M.D. Distinguished Professorship in Clinical Education at UT Southwestern Medical Center in Dallas, Texas. He is a medical oncologist who specializes in experimental therapeutics and the treatment of lung cancers. In addition, Dr. Johnson is the Emeritus Chair of the LCFA Scientific Advisory Board.
Dr. Julie Brahmer
Dr. Brahmer is a global thought leader in the emerging field of immunotherapy. Her research and clinical practice focus on the development of new therapies, including immunotherapies, for the treatment and prevention of lung cancer and mesothelioma.
Dr. Brahmer is the Co-Director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University.
